CN1422534A - Peptide milk powder and its preparation technology - Google Patents

Peptide milk powder and its preparation technology Download PDF

Info

Publication number
CN1422534A
CN1422534A CN 02153207 CN02153207A CN1422534A CN 1422534 A CN1422534 A CN 1422534A CN 02153207 CN02153207 CN 02153207 CN 02153207 A CN02153207 A CN 02153207A CN 1422534 A CN1422534 A CN 1422534A
Authority
CN
China
Prior art keywords
milk
peptide
powder
water
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 02153207
Other languages
Chinese (zh)
Other versions
CN1186985C (en
Inventor
张剑平
郝在林
路振霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inner Mongolia Peihao Biological Products Co ltd
Original Assignee
XILINGGOL LEAGUE XINTAI BIOLOGICAL PRODUCT CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XILINGGOL LEAGUE XINTAI BIOLOGICAL PRODUCT CO Ltd filed Critical XILINGGOL LEAGUE XINTAI BIOLOGICAL PRODUCT CO Ltd
Priority to CNB021532079A priority Critical patent/CN1186985C/en
Publication of CN1422534A publication Critical patent/CN1422534A/en
Application granted granted Critical
Publication of CN1186985C publication Critical patent/CN1186985C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a peptide milk powder and its preparation process. It is formed from five raw materials of fresh milk, bone marrow powder, white granulated sugar, soda and water. Said invention also provides its formula and technological process. Said product has several health-care functions of regulating immunological function of human body, promoting metabolism of cell, balancing cell nutrient, promoting absorption of milk components and others.

Description

Peptide milk powder and preparation technology thereof
Technical field
The present invention relates to the required food of human lives, specifically relate to new peptide milk powder and preparation technology thereof.
Background technology
Development along with protein biochemistry, physiology and nutrition, it is found that, the mankind ingest protein after the effect of digestive enzyme, are not to absorb with amino acid whose form as thinking in the past, more are to absorb with low peptide (as two, tripeptides etc.) form.The absorptivity of low peptide is absorbed by body than amino acid is easier, faster than amino acid height.Some low peptide can not only provide people's bulk-growth, grow required nutriment, and has the effect of preventing and curing diseases, regulating human physiological functions simultaneously, some is the physiological function of former food protein or the unexistent uniqueness of its composition amino acid, and the composition amino acid of many active peptides might not be essential amino acid.Therefore the research and development of biologically active peptide have become the urgent problem of food educational circles.
Summary of the invention
The objective of the invention is to overcome above-mentioned the deficiencies in the prior art part, and easily manufactured, effective peptide milk powder (trade name: sunrise is peptide milk powder too) and preparation technology thereof is provided.
The object of the invention can realize by following measure:
Peptide milk powder is to be made by following raw material and prescription:
Plain chocolate 94-96%
White granulated sugar 2-3%
Bone marrow peptide 2-4%
The content sum of above each component percentage by weight is 100%, water dissolved sugar and marrow powder, water and contain a little soda ash and all ignore.
The technology of preparation peptide milk powder, as follows:
1, milk collection
Regain fresh milk from the pasture, through outgasing, filter, cool off, go into milk-storage tank.
2, give processing
1) adjustment of marrow powder pH value
Accurately metering marrow powder is used the hot water dissolving, and it is 7.0 that soda ash liquid is adjusted pH value, and cooling is left standstill.
2) pure milk gives processing
The pure milk of refrigeration is squeezed into compensating groove, heating, centrifugal, squeeze into allotment.
3) allotment of peptide milk
With the dissolving of granulated sugar water, add in the milk with peptide liquid, stir.
4) concentrate
The peptide milk liquid for preparing vacuum after filtration concentrates.
5) spraying
Dense milk temperature is at 45-50 ℃, and powder is cooled off, sieved to spray-drying, packing.
Bone marrow peptide is the biologically active of extracting from cattle and sheep fresh bone meat tissue, is had " regulating immunity " health care foods by health ministry approval production in 1997.This active peptide product is added in the milk, and the peptide milk powder of making has immunoregulatory effect undoubtedly.
Bone marrow peptide opaque amount standard sees the following form:
The bone marrow peptide sample is delivered to nutrition and food hygiene teaching and research room of Beijing Medical University, and this teaching and research room has made health food immunoregulation effect survey report, now assay is presented below: test rating:
Spleen of mouse and thymus gland are heavy; Antibody forming cell's (PFC) mensuration improves slide method with Jerne; Delayed allergy (DTH) is measured with the pedal swelling method; The detection of macrophage phagocytic function adopts the carbon particle clearance method to measure statistical method: with two groups of mean checks.Animal used as test:
Kunming kind male and female mouse, age in 6-8 week, 18-22 gram, scientific experiment animal portion of Beijing Medical University provides, and the quality certification number is: the moving word 01-3049 of doctor.Experimental design:
Animal is divided control group, low dose group, middle dosage group and high dose group.The dosage of above-mentioned three experimental group is respectively 0.25g/Kg, 1.0g/Kg and 3.0g/Kg body weight.Be equivalent to 2.5,10 and 30 times of people's consumption every day respectively, the continuous irrigation stomach is 14 days altogether.Measurement result:
1, thymic weight of each dosage group mouse and control group more all have tangible increase, and mouse spleen weight and control group are not seen significant change (table 1).
2, middle and high dosage group mouse IgM-PFC number/full spleen and apparent in view increase (table 2) of control group.
3, the delayed allergy of high dose group mouse (DTH) relatively has obvious enhancing with control group, and low, middle dosage group and control group are not seen significant change (table 3).
4, each dosage group mouse carbon particle clearance rate (K) and clean up index (a) and control group and do not see significant change (table 4).
Table 1 bone marrow peptide is to mouse immune organ weight's influence (X ± S)
Group n Spleen phase counterweight Thymus gland phase counterweight
Solvent control 12 ?5.82±1.31 ?3.70±0.68
Low dose group 12 ?5.81±1.56 ?4.58±1.10*
Middle dosage group 12 ?5.71±1.13 ?4.54±1.27*
High dose group 12 ?5.54±1.16 ?4.48±1.02*
Heavy (the mg)/body weight of phase counterweight=internal organs (g) compare with control group *P<0.05
Table 2 bone marrow peptide is to the influence of mouse IgM-PFC/ spleen
Figure A0215320700071
Figure A0215320700072
Compare with control group *P<0.01
Table 3 bone marrow peptide is to the influence of mouse DTH reaction (X ± S)
Group n The foot sole of the foot increases thickness (mm)
Solvent control 12 ?0.52±0.14
Low dose group 12 ?0.52±0.17
Middle dosage group 12 ?0.63±0.18
High dose group 12 ?0.66±0.18*
Compare with control group *P<0.05
Table 4 bone marrow peptide is to the influence of mouse carbon particle clearance (X ± S)
Group ??n ??K ??α
Solvent control ??11 ??0.0436±0.0180 ??6.80±0.77
Low dose group ??11 ??0.0471±0.0077 ??6.94±0.62
Middle dosage group ??11 ??0.0559±0.0202 ??6.88±0.73
High dose group ??12 ??0.0380±0.0082 ??6.81±0.49
Brief summary as a result:
Its mouse oral gave bone marrow peptide after 14 days, and testing result shows that bone marrow peptide is significantly increased mouse thymus weight, strengthened the effect of humoral immune function (IgM-PFC) and cellular immune function (DTH), and not seeing significantly influences macrophage phagocytic function.
The key problem in technology point is the pH value of peptide
The final pH value of peptide powder with zymolysis technique production is 6.0, and the pH value of fresh milk is generally 6.5~6.8.If directly the peptide powder being mixed with solution adds in the pure milk, will destroy the balance of the original system of fresh milk, the result is that lamination appears in liquid peptide milk; If make peptide milk powder, after molten, the dough of floating a large amount of indissolubles on the liquid level, after the placement room temperature, the cup end, form white precipitate.If peptide liquid pH value is adjusted to the pH value identical with fresh milk, this phenomenon still exists.In order to address this problem, liquid towards milk has adopted a lot of measures, finds the binding site that combines the best of peptide and milk finally, this point is exactly a pH value 7.0, peptide liquid pH value is adjusted to 7.0, add in the pure milk, neither influence the stability that taste does not influence whole mixed system.
The present invention's milk compared to existing technology has following advantage: product of the present invention promotes cell metabolism to people's physical efficiency regulatory function, and statocyte nutrition improves body immunity, promotes the absorption of milk constituents.
The specific embodiment
Enumerate an embodiment below, the present invention is further specified.
Embodiment 1: it is as follows to fill a prescription:
The raw material kilogram
Plain chocolate 945
White granulated sugar 25
Marrow powder 30
Add a little soda ash, more than four raw material total amounts be 1000 kilograms.
With the fresh milk that regain in the pasture, pour compensating groove into, through outgasing, filtering, be cooled to 0-4 ℃, squeeze into milk-storage tank, processing is given in refrigeration, the marrow powder is accurately measured 30 kilograms, with 60 ℃ of water-soluble separating, transfer pH value to 7.0 with soda ash, be cooled to below 10 ℃, leave standstill 10 hours stand-by.The plain chocolate of refrigeration is squeezed into compensating groove for 945 kilograms, be heated to 35-40 ℃ by plate type heat exchanger, allotment is squeezed in centrifugal cooling, the allotment of peptide milk: with 25 kilograms of dissolvings of granulated sugar, add in the cow's milk with the marrow powder, stir.The peptide milk for preparing is concentrated into 12-16mmHg/50 ℃ through vacuum, and dense milk temperature can be carried out spray-drying immediately at 45-50 ℃, again through cooling off, sieve powder, being packaged into peptide milk powder.

Claims (2)

1, peptide milk powder is characterized in that being made up of following raw material and prescription:
Plain chocolate 94-96%
White granulated sugar 2-3%
Marrow powder 2-4%
The content sum of above each component percentage by weight is 100%, water dissolved sugar and marrow powder, water and contain a little soda ash and all ignore.
2, preparation is characterized in that as follows as the technology of claim 1 peptide milk:
1, milk collection
Regain fresh milk from the pasture, through outgasing, filter, cool off, go into milk-storage tank;
2, give processing
1) adjustment of marrow powder pH value
Accurately metering marrow powder is used the hot water dissolving, and it is 7.0 that soda ash liquid is adjusted pH value, and cooling is left standstill;
2) pure milk gives processing
The pure milk of refrigeration is squeezed into compensating groove, heating, centrifugal, squeeze into allotment;
3) allotment of peptide milk
With the dissolving of granulated sugar water, add in the milk with peptide liquid, stir;
4) concentrate
The peptide milk liquid for preparing vacuum after filtration concentrates;
5) spraying
Dense milk temperature is at 45-50 ℃, and powder is cooled off, sieved to spray-drying, packing.
CNB021532079A 2002-11-26 2002-11-26 Peptide milk powder and its preparation technology Expired - Fee Related CN1186985C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021532079A CN1186985C (en) 2002-11-26 2002-11-26 Peptide milk powder and its preparation technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021532079A CN1186985C (en) 2002-11-26 2002-11-26 Peptide milk powder and its preparation technology

Publications (2)

Publication Number Publication Date
CN1422534A true CN1422534A (en) 2003-06-11
CN1186985C CN1186985C (en) 2005-02-02

Family

ID=4752208

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021532079A Expired - Fee Related CN1186985C (en) 2002-11-26 2002-11-26 Peptide milk powder and its preparation technology

Country Status (1)

Country Link
CN (1) CN1186985C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315391C (en) * 2004-06-30 2007-05-16 李宝曌 Milk powder and its preparing method
CN101623034B (en) * 2008-07-08 2012-05-30 内蒙古伊利实业集团股份有限公司 Liquid dairy product containing egg yolk polypeptide and method of producing same
CN103250791A (en) * 2013-04-24 2013-08-21 江西雄鹰乳业有限公司 Milk powder used for preventing and treating osteoporosis
CN109122870A (en) * 2018-08-15 2019-01-04 西安安诺乳业有限公司 Quinquagenarian formula milk powder and preparation method thereof containing maca and ox bone marrow polypeptide

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1315391C (en) * 2004-06-30 2007-05-16 李宝曌 Milk powder and its preparing method
CN101623034B (en) * 2008-07-08 2012-05-30 内蒙古伊利实业集团股份有限公司 Liquid dairy product containing egg yolk polypeptide and method of producing same
CN103250791A (en) * 2013-04-24 2013-08-21 江西雄鹰乳业有限公司 Milk powder used for preventing and treating osteoporosis
CN109122870A (en) * 2018-08-15 2019-01-04 西安安诺乳业有限公司 Quinquagenarian formula milk powder and preparation method thereof containing maca and ox bone marrow polypeptide

Also Published As

Publication number Publication date
CN1186985C (en) 2005-02-02

Similar Documents

Publication Publication Date Title
US10548933B2 (en) Method for preparing broccoli protein peptide mixture
CN1299724C (en) Health care products of lucid ganoderma and their preparation
CN106578078A (en) Efficient-absorption oligopeptide formula goat milk powder and preparation method thereof
CN108113007A (en) A kind of composition containing soybean protein and yak marrow and preparation method thereof
CN109757733A (en) A kind of oral polypeptide powder and its preparation method and application
CN1643130A (en) A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug
CN110172491B (en) Multi-element biological protein peptide and preparation method thereof
CN105079028A (en) Health care product capable of improving bones and joints and preparation method of health care product
CN101279089B (en) Donkey-hide gelatin calcium composition and preparing process thereof
CN1186985C (en) Peptide milk powder and its preparation technology
CN114891067B (en) Dandelion anti-inflammatory active peptide and preparation method and application thereof
CN111802646A (en) A nutritional composition for preventing muscle decay and its preparation method
CN1049097C (en) Super concentrated fodder for ruminant
CN113854574B (en) Novel compound bone peptide and application thereof
CN114854604B (en) Ganoderma lucidum, high-concentration oral liquid containing ganoderma lucidum and preparation method thereof
KR102553252B1 (en) Mnufacturing mathod of the nutrition snack with enhancing immune activity for companion dogs using Gyoungokgo
CN109497470A (en) A kind of chlorella pyrenoidosa polypeptide alleviates getting fat composition and preparation method thereof
CN1240297C (en) Peptide milk and its preparation technology
CN107348250A (en) A kind of hirudinaria manillensis feed and preparation method thereof
CN115989871A (en) Composition for promoting growth and development as well as preparation method and application thereof
CN1233377C (en) Fat reducing Chinese drugs for treating simple obesity
CN104939098A (en) Health food capable of enhancing bone immunity and supplementing and locking calcium and preparation method of health food
CN111357870A (en) Recovery period pet diet for wound healing
CN1225215C (en) Health care foodstuff containing polysaccharide and method for preparing the same
CN114145356B (en) Formula milk powder capable of improving immune response and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: Xilinhaote city the Inner Mongolia Autonomous Region Ximeng Hanggai Road No. 256

Patentee after: XILINGOL LEAGUE TAIHAO BIOLOGICAL PRODUCTS Co.,Ltd.

Address before: Xilinhaote city the Inner Mongolia Autonomous Region Ximeng Hanggai Road No. 256

Patentee before: XINTAI BIOLOG PRODUCT LLC XILI

CP01 Change in the name or title of a patent holder
CP03 Change of name, title or address

Address after: 176 Hanggai Road, Xilinhaote City, Xilinguole League, Inner Mongolia Autonomous Region

Patentee after: Inner Mongolia Peihao Biological Products Co.,Ltd.

Address before: Xilinhaote city the Inner Mongolia Autonomous Region Ximeng Hanggai Road No. 256

Patentee before: XILINGOL LEAGUE TAIHAO BIOLOGICAL PRODUCTS Co.,Ltd.

CP03 Change of name, title or address
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050202

Termination date: 20211126

CF01 Termination of patent right due to non-payment of annual fee